BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,537,636 | -26.2% | 105,515 | -2.0% | 0.04% | -17.0% |
| Q2 2023 | $3,439,244 | +4.2% | 107,712 | -0.1% | 0.05% | -14.5% |
| Q1 2023 | $3,301,173 | -21.9% | 107,811 | -0.3% | 0.06% | -30.4% |
| Q4 2022 | $4,228,417 | -25.6% | 108,116 | -9.3% | 0.08% | -20.2% |
| Q3 2022 | $5,680,000 | +11.4% | 119,221 | -9.5% | 0.10% | +8.8% |
| Q2 2022 | $5,101,000 | -43.5% | 131,777 | -16.4% | 0.09% | +9.6% |
| Q1 2022 | $9,031,000 | -27.4% | 157,609 | +0.9% | 0.08% | +16.9% |
| Q4 2021 | $12,442,000 | -5.6% | 156,131 | +3.0% | 0.07% | +4.4% |
| Q3 2021 | $13,186,000 | -29.0% | 151,546 | +5.1% | 0.07% | -25.3% |
| Q2 2021 | $18,562,000 | +61.2% | 144,219 | +0.2% | 0.09% | +46.8% |
| Q1 2021 | $11,518,000 | +8.8% | 143,900 | +10.9% | 0.06% | +17.0% |
| Q4 2020 | $10,590,000 | +304.8% | 129,711 | +22.1% | 0.05% | +231.2% |
| Q3 2020 | $2,616,000 | +2.5% | 106,263 | +16.6% | 0.02% | -20.0% |
| Q2 2020 | $2,551,000 | +57.8% | 91,105 | +1.4% | 0.02% | +5.3% |
| Q1 2020 | $1,617,000 | – | 89,813 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |